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Lead and Hypertension in a Mortality
Study of Lead Smelter Workers
by Sherry G. Selevan,* Philip J. Landrigan,t
Frank B. Stern,t and James H. Jonest
Hypertension has been associated with occupational
lead exposure (1-3), and may in part be a consequence
of renal injury. Excess mortality from cerebrovascular
disease (1,4,5) and other forms of hypertensive vascu-
lopathy (6), as well as from chronic renal disease (4-7),
have been found in previous studies of lead smelter
and battery workers. To assess the epidemiology of
death potentially associated with lead-induced hyper-
tension, we have reviewed data from a larger study (8).
This study evaluated the mortality of a cohort of
white, male, hourly workers hired at a lead smelter in
Idaho between January 1, 1940, and December 31, 1965,
and employed for at least 1 year. Mortality was deter-
mined as of December 1, 1977. Of the 1987 males
qualifying for the study group, 1281 were known to be
alive, 665 were known to be deceased (601 death certifi-
cates were obtained), and the remainder (2.1%) were
lost to follow-up. The deaths in this population were
compared to the U.S. white male population using a
Standardized Mortality Ratio analysis (SMR).
This plant was a primary smelter. The workers were
exposed to cadium, zinc, and arsenic, as well as to lead.
Therefore, a scheme was developed (8) to categorize
exposures into several groupings based on the worker's
probability for high lead exposure, with or without
high exposure to cadmium, zinc, and arsenic. These
groups were named "high lead" (HL) and "high
lead/low other" (HL/LO).
The SMR for all causes for the entire population was
98, a value close to the norm for the U.S. population. As
is usually found in studies of occupational popula-
tions, there was a statistically significant decrease in
mortality for circulatory system disease; this probably
is the result of selection factors typically found in work
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forces, the so-called "healthy worker effect" (9). Mor-
tality from hypertension with heart disease had an
overall SMR of 61 (confidence limits, 22-133; power or
ability to detect a doubling = 74%); for hypertension
without heart disease, the overall SMR was 117
(confidence limits, 24-342; power = 26%). Mortality
from stroke was reduced (SMR = 84; confidence limits,
61-112), but not significantly so. These findings
remained unchanged when examined by duration of
exposure and by latency (Table 1) and when the data
were examined by HL and HL/LO subgroups.
The findings on renal disease and cancer are more
suggestive of an association with lead exposure: For
the total population, mortality from chronic and un-
specified nephritis' and other renal sclerosis [Inter-
national Classification of Diseases (ICD) 591-594] was
elevated but not significantly so (SMR = 192; confi-
dence limits, 88-364); the findings for this category for
the HL and HL/LO groups was similar. In addition,
the SMRs for the highest exposures and latency
categories for the total study group were over 300 and
statistically significant (Table 1). For mortality from
kidney cancer, the overall SMR was 204 (confidence
limits, 75-444), which increased to 245 (confidence
limits, 81-583) for the HL group and to 301 (confidence
limits, 98-703; power = 28%o) for the HL/LO group.
In summary, these data do not suggest an associa-
tion between occupational lead exposure and mortality
from hypertension. The power of the study to detect
excess mortality from hypertension with heart disease
was fairly high (power = 74%), but it was quite low for
hypertension without heart disease (power = 26%).
These data do, however, suggest an association between
lead and renal disease and possibly renal cancer. Ne-
phritis has been recognized as a component of occu-
pational lead intoxication since the late 19th century,
and although little is known about natural history
and dose-response relationships for lead-related renal
effects, mortality from renal disease in this population
appears to be associated with long-term, high lead
exposures. This finding is consistent with epidemi-66 SELEVANETAL.
Table 1. Mortality experience ofworkers at a primary lead smelter, 1940-1977.
Cause ofdeath < 5 years 5-19years 20 years
(ICD codes, 7th revision) Observed SMR (CL)a Observed SMR (CL) Observed SMR (CL)
Diseases ofthe circulatory system (400-468)
Duration ofexposure 91 76 (61-93) 89 75 (60-92) 66 87 (67-111)
Latency interval 2 20 (2-71) 64 66 (51- 84) 180 87 (74-100)
Hypertension with heartdisease (440_443)b
Duration ofexposure 1 2 52 (6-188) 3 116 (24-340)
Latency interval 0 0 6 105 (38-228)
Hypertension withoutheart disease (444447)b
Duration ofexposure 1 1 1
Latency interval 0 1 - 2 120 (15 -433)
Renal disease and cancer
Kidney cancer (180)
Duration ofexposure 2 165 (20-597) 3 278 (57-812) 1
Latency interval 1 1 4 214 (58-548)
Renal disease (nephritis and
nephrosis) (591-594)
Duration ofexposure 3 160 (33-469) 2 112 (14-404) 4 392 (107-1004)
Latencyinterval 0 2 98 (12-352) 7 315 (127-649)
Totalforall causes
Duration ofexposure 265 98 (87-111) 232 92 (80-104) 168 109 (93-127)
Latencyinterval 19 65 (39-101) 208 94 (82-108) 438 103 (93-113)
aCL, confidence limits.
bDue to changes in ICD coding, these datareferonly to deaths occurring after 1950.
ologic reports of chronic renal disease (1,5-7) and case
reports of renal cancer (10,11) in workers, as well as
renal cancer in rats, mice, and hamsters (10-16).
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